Breaking News Instant updates and real-time market news.

2023-01-23 07:09:57 AMK AssetMark Financial $24.77 / +0.51 (+2.10%) 07:09 01/23/23 01/23 07:09 01/23/23 07:09	JPMorgan upgrades AssetMark Financial on medium term position JPMorgan analyst Michael Cho upgraded AssetMark Financial to Overweight from Neutral with a price target of $32, up from $24. The analyst thinks the independent advisor space will continue to benefit from industry secular tailwinds. The service providers that cater to independent financial advisors continue to gain traction, the firm tells investors in a research note. Despite the uncertain near-term market and macro backdrop, companies like AssetMark remain well positioned over the medium term, JPMorgan contends. The analyst says the wealth industry is benefitting from a rise in demand for financial advice while the wirehouses continue to cede share. The firm upgraded small-cap idea AssetMark on expectations for continued solid execution, self-help margin expansion, its higher sensitivity to markets, and an "unassuming" valuation.

2023-01-23 07:09:57

AMK

AssetMark Financial

$24.77 / +0.51 (+2.10%)

07:09

01/23/23

01/23

07:09

01/23/23

07:09

JPMorgan upgrades AssetMark Financial on medium term position

JPMorgan analyst Michael Cho upgraded AssetMark Financial to Overweight from Neutral with a price target of $32, up from $24. The analyst thinks the independent advisor space will continue to benefit from industry secular tailwinds. The service providers that cater to independent financial advisors continue to gain traction, the firm tells investors in a research note. Despite the uncertain near-term market and macro backdrop, companies like AssetMark remain well positioned over the medium term, JPMorgan contends. The analyst says the wealth industry is benefitting from a rise in demand for financial advice while the wirehouses continue to cede share. The firm upgraded small-cap idea AssetMark on expectations for continued solid execution, self-help margin expansion, its higher sensitivity to markets, and an "unassuming" valuation.

OTHER BREAKING NEWS FROM THE FLY

Downgrade	SSAB AB downgraded to Equal Weight from Overweight at Morgan Stanley » 04:44 02/03/23 02/03 04:44 02/03/23 04:44 SSAAY SSAB AB $3.51 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research On The Fly SSAAY SSAB AB $3.51 / + (+0.00%) 02/02/23 Kepler Cheuvreux SSAB AB downgraded to Hold from Buy at Kepler Cheuvreux 02/01/23 Barclays SSAB AB price target raised to SEK 72 from SEK 65 at Barclays 01/30/23 Deutsche Bank SSAB AB price target raised to SEK 71 from SEK 68 at Deutsche Bank 01/30/23 JPMorgan SSAB AB price target raised to SEK 59 from SEK 55 at JPMorgan SSAAY SSAB AB $3.51 / + (+0.00%) 12/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Downgrade	Friedrich Vorwerk downgraded to Hold from Buy at Berenberg » 04:43 02/03/23 02/03 04:43 02/03/23 04:43 FRVWY Friedrich Vorwerk $3.50 / -0.25 (-6.67%) Berenberg analyst Lasse… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FRVWY Friedrich Vorwerk $3.50 / -0.25 (-6.67%) 01/31/23 Jefferies Vorwerk Group SE downgraded to Hold from Buy at Jefferies
Downgrade	Asos downgraded to Hold from Buy at Deutsche Bank » 04:40 02/03/23 02/03 04:40 02/03/23 04:40 ASOMY Asos $12.01 / +0.83 (+7.42%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ASOMY Asos $12.01 / +0.83 (+7.42%) 02/01/23 HSBC Asos upgraded to Hold from Reduce at HSBC 01/24/23 Morgan Stanley Asos price target raised to 730 GBp from 660 GBp at Morgan Stanley 01/13/23 JPMorgan Asos price target lowered to 1,000 GBp from 1,170 GBp at JPMorgan 01/13/23 Societe Generale Asos price target raised to 1,180 GBp from 1,072 GBp at Societe Generale
Downgrade	Pets at Home Group downgraded to Hold from Buy at Deutsche Bank » 04:39 02/03/23 02/03 04:39 02/03/23 04:39 PAHGF Pets at Home Group $3.42 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PAHGF Pets at Home Group $3.42 / + (+0.00%) 02/02/23 Liberum Pets at Home Group downgraded to Hold from Buy at Liberum 11/03/22 Berenberg Pets at Home Group price target lowered to 370 GBp from 470 GBp at Berenberg 08/09/22 Jefferies Pets at Home Group initiated with a Buy at Jefferies 07/04/22 RBC Capital Pets at Home Group downgraded to Underperform from Sector Perform at RBC Capital
Downgrade	Kingfisher downgraded to Hold from Buy at Deutsche Bank » 04:39 02/03/23 02/03 04:39 02/03/23 04:39 KGFHY Kingfisher $7.17 / +0.26 (+3.76%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KGFHY Kingfisher $7.17 / +0.26 (+3.76%) 12/02/22 Deutsche Bank Kingfisher price target lowered to 275 GBp from 280 GBp at Deutsche Bank 11/17/22 JPMorgan Kingfisher price target lowered to 210 GBp from 220 GBp at JPMorgan 11/07/22 Credit Suisse Kingfisher downgraded to Neutral from Outperform at Credit Suisse 09/27/22 Deutsche Bank Kingfisher price target raised to 280 GBp from 270 GBp at Deutsche Bank
Upgrade	Inditex upgraded to Hold from Sell at Deutsche Bank » 04:38 02/03/23 02/03 04:38 02/03/23 04:38 IDEXY Inditex $15.76 / -0.19 (-1.19%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IDEXY Inditex $15.76 / -0.19 (-1.19%) 12/16/22 Societe Generale Inditex downgraded to Hold from Buy at Societe Generale 12/15/22 Deutsche Bank Inditex price target raised to EUR 23 from EUR 22.50 at Deutsche Bank 12/02/22 Morgan Stanley Inditex assumed with an Equal Weight at Morgan Stanley 09/15/22 Credit Suisse Inditex price target raised to EUR 21.50 from EUR 20.50 at Credit Suisse
Upgrade	B&M European Value Retail upgraded to Buy from Hold at Deutsche Bank » 04:37 02/03/23 02/03 04:37 02/03/23 04:37 BMRRY B&M European Value Retail $23.34 / +0.85 (+3.78%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BMRRY B&M European Value Retail $23.34 / +0.85 (+3.78%) 01/06/23 JPMorgan B&M European Value price target lowered to EUR 540 from EUR 555 at JPMorgan 01/06/23 Barclays B&M European Value price target raised to 485 GBp from 475 GBp at Barclays 01/06/23 Deutsche Bank B&M European Value price target raised to 460 GBp from 415 GBp at Deutsche Bank 12/30/22 Credit Suisse Credit Suisse sees some U.K. retailers increasing guidance
Upgrade	Marks & Spencer upgraded to Buy from Hold at Deutsche Bank » 04:37 02/03/23 02/03 04:37 02/03/23 04:37 MAKSY Marks & Spencer $4.00 / +0.19 (+4.99%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research MAKSY Marks & Spencer $4.00 / +0.19 (+4.99%) 09/30/22 Linde completes sale of Gist to Marks & Spencer MAKSY Marks & Spencer $4.00 / +0.19 (+4.99%) 01/13/23 Barclays Marks & Spencer price target raised to 165 GBp from 155 GBp at Barclays 01/13/23 JPMorgan Marks & Spencer price target raised to 115 GBp from 100 GBp at JPMorgan 01/13/23 Citi Marks & Spencer price target raised to 150 GBp from 125 GBp at Citi 12/30/22 Credit Suisse Credit Suisse sees some U.K. retailers increasing guidance
Upgrade	Standard Chartered upgraded to Buy from Hold at Investec » 04:34 02/03/23 02/03 04:34 02/03/23 04:34 SCBFF Standard Chartered $8.15 / + (+0.00%) Investec analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SCBFF Standard Chartered $8.15 / + (+0.00%) 02/01/23 Goldman Sachs Standard Chartered downgraded to Neutral from Buy at Goldman Sachs 01/16/23 Deutsche Bank Standard Chartered downgraded to Hold from Buy at Deutsche Bank 01/06/23 Investec Standard Chartered downgraded to Hold from Buy at Investec 12/06/22 JPMorgan Standard Chartered price target raised to 800 GBp from 770 GBp at JPMorgan
Recommendations	Amazon.com price target raised to $123 from $119 at Piper Sandler » 04:32 02/03/23 02/03 04:32 02/03/23 04:32 AMZN Amazon.com $112.65 / +7.48 (+7.11%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $112.65 / +7.48 (+7.11%) 02/02/23 Amazon says YTD AWS revenue growth in mid-teens y/y so far 02/02/23 Amazon saw continued efficiencies in transportation network in Q4 02/02/23 Amazon down 5% ahead of Q4 earnings call 02/02/23 Amazon down fractionally after Q4 report, Q1 guidance AMZN Amazon.com $112.65 / +7.48 (+7.11%) 02/02/23 Morgan Stanley Meta Platforms price target raised to $190 from $130 at Morgan Stanley 02/01/23 Oppenheimer Oppenheimer says channel checks support below-consensus AWS estimates 02/01/23 Morgan Stanley Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley 01/30/23 UBS Amazon's Buy with Prime puts up to 14% of Shopify revenue at risk, says UBS AMZN Amazon.com $112.65 / +7.48 (+7.11%) 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 02/02/23 Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c 02/02/23 Notable companies reporting after market close 10/27/22 Amazon sees Q4 revenue $140B-$148B, consensus $155.15B AMZN Amazon.com $112.65 / +7.48 (+7.11%) 02/02/23 Beyond Meat revamps retail sales strategy around five grocers, WSJ says 02/01/23 Judge rules Amazon supervisors broke law in anti-union efforts, NYTimes reports 02/01/23 Amazon's layoffs hit robotics, grocery, health, AWS units, CNBC reports 01/29/23 Amazon raises price minimum for free grocery delivery, WSJ reports AMZN Amazon.com $112.65 / +7.48 (+7.11%) 02/02/23 Fly Intel: After-Hours Movers 02/02/23 What Wall Street is saying about Alphabet ahead of earnings 02/01/23 Here's what Wall Street is saying about Amazon ahead of earnings 01/30/23 Fly Intel: Pre-market Movers 02/13/23 Technology/Finance AMZN Amazon.com $112.65 / +7.48 (+7.11%) 02/02/23 Amazon options imply 7.0% move in share price post-earnings 02/02/23 Notable open interest changes for February 2nd 01/31/23 Notable open interest changes for January 31st 01/30/23 Notable open interest changes for January 30th

Recommendations	Alphabet price target lowered to $120 from $122 at Piper Sandler » 04:30 02/03/23 02/03 04:30 02/03/23 04:30 GOOGL Alphabet $107.71 / +7.275 (+7.24%) , GOOG Alphabet $108.77 / +7.375 (+7.27%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GOOGL GOOG GOOGL Alphabet $107.71 / +7.275 (+7.24%) 02/02/23 Alphabet says started bringing revenue sharing to YouTube Shorts 02/02/23 Alphabet reports Q4 Google Cloud revenue $7.3B vs. $5.54B last year 02/02/23 Alphabet taking actions to optimize global office space 02/01/23 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14 GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Alphabet says started bringing revenue sharing to YouTube Shorts 02/02/23 Alphabet reports Q4 Google Cloud revenue $7.3B vs. $5.54B last year 02/02/23 Alphabet taking actions to optimize global office space 02/01/23 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14 GOOGL GOOG GOOGL Alphabet $107.71 / +7.275 (+7.24%) 02/02/23 Morgan Stanley Meta Platforms price target raised to $190 from $130 at Morgan Stanley 01/31/23 BofA Alphabet price target raised to $119 at BofA ahead of earnings 01/30/23 KeyBanc Trade Desk price target lowered to $55 from $56 at KeyBanc 01/30/23 KeyBanc Alphabet price target lowered to $117 from $118 at KeyBanc GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Morgan Stanley Meta Platforms price target raised to $190 from $130 at Morgan Stanley 01/31/23 BofA Alphabet price target raised to $119 at BofA ahead of earnings 01/30/23 KeyBanc Trade Desk price target lowered to $55 from $56 at KeyBanc 01/30/23 KeyBanc Alphabet price target lowered to $117 from $118 at KeyBanc GOOGL GOOG GOOGL Alphabet $107.71 / +7.275 (+7.24%) 02/02/23 Alphabet reports Q4 EPS $1.05, consensus $1.18 02/02/23 Notable companies reporting after market close 10/25/22 Alphabet reports Q3 EPS $1.06, consensus $1.25 10/25/22 Notable companies reporting after market close GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Alphabet reports Q4 EPS $1.05, consensus $1.18 02/02/23 Notable companies reporting after market close 10/25/22 Alphabet reports Q3 EPS $1.06, consensus $1.25 10/25/22 Notable companies reporting after market close GOOGL GOOG GOOGL Alphabet $107.71 / +7.275 (+7.24%) 02/02/23 Democratic senator joins calls to ban TikTok, WSJ reports 02/01/23 GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports 02/01/23 Google testing ChatGPT-like products, including 'Apprentice Bard,' CNBC reports 01/31/23 Reels sharing revenue with creators hotly debated within Meta, Information says GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Democratic senator joins calls to ban TikTok, WSJ reports 02/01/23 GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports 02/01/23 Google testing ChatGPT-like products, including 'Apprentice Bard,' CNBC reports 01/31/23 Reels sharing revenue with creators hotly debated within Meta, Information says GOOGL GOOG GOOGL Alphabet $107.71 / +7.275 (+7.24%) 02/02/23 Fly Intel: After-Hours Movers 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 02/02/23 What Wall Street is saying about Alphabet ahead of earnings GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 02/02/23 What Wall Street is saying about Alphabet ahead of earnings 02/01/23 #SocialStocks: Meta circumvents FTC challenge and will acquire Within Unlimited GOOGL GOOG GOOGL Alphabet $107.71 / +7.275 (+7.24%) 02/02/23 Alphabet Class A options imply 5.4% move in share price post-earnings 02/02/23 Early notable gainers among liquid option names on February 2nd 01/20/23 Early notable gainers among liquid option names on January 20th 01/20/23 Unusually active option classes on open January 20th GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Alphabet options imply 5.9% move in share price post-earnings 01/20/23 Unusually active option classes on open January 20th 12/14/22 Alphabet put buyer realizes 126% same-day gains 11/02/22 Alphabet put buyer realizes 98% same-day gains
Recommendations	Gilead price target raised to $112 from $111 at Piper Sandler » 04:28 02/03/23 02/03 04:28 02/03/23 04:28 GILD Gilead $81.37 / -2.625 (-3.13%) Piper Sandler analyst Do… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options GILD Gilead $81.37 / -2.625 (-3.13%) 02/02/23 Gilead raises quarterly dividend 2.7% to 75c per share 01/30/23 Kite and Arcellx close pact to develop late-stage clinical CART-ddBCMA in MM 01/04/23 Hookipa Pharma achieves $5M milestone payment from Gilead 01/03/23 EVOQ to potentially receive $658.5M in Gilead collaboration on immunotherapies GILD Gilead $81.37 / -2.625 (-3.13%) 01/30/23 Truist Truist sees potential pressure on Seagen's Padcev in Q4 01/19/23 Piper Sandler Gilead price target raised to $111 from $104 at Piper Sandler 01/03/23 RBC Capital RBC downgrades Gilead, says drivers need time to play out 01/03/23 RBC Capital Gilead downgraded to Sector Perform from Outperform at RBC Capital GILD Gilead $81.37 / -2.625 (-3.13%) 02/02/23 Gilead sees FY23 adjusted EPS $6.60-$7.00, consensus $6.73 02/02/23 Gilead reports Q4 adjusted EPS $1.67, consensus $1.49 02/02/23 Notable companies reporting after market close 12/20/22 Gilead expects Tmunity acquisition to reduce FY23 EPS by 18c-22c GILD Gilead $81.37 / -2.625 (-3.13%) 02/02/23 Fly Intel: After-Hours Movers 12/30/22 What You Missed On Wall Street This Morning 12/30/22 Biotech Alert: Searches spiking for these stocks today 12/28/22 What You Missed On Wall Street On Wednesday 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 02/12/23 PDUFA Date for TRODELVY 02/07/23 Gilead 02/08/23 Gilead GILD Gilead $81.37 / -2.625 (-3.13%) 02/02/23 Gilead options imply 3.5% move in share price post-earnings 11/02/22 Unusually active option classes on open November 2nd 10/28/22 Early notable gainers among liquid option names on October 28th 10/27/22 Gilead options imply 2.6% move in share price post-earnings
Recommendations	Conmed price target raised to $118 from $108 at Piper Sandler » 04:27 02/03/23 02/03 04:27 02/03/23 04:27 CNMD Conmed $107.27 / +8.02 (+8.08%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Conmed: Results impacted by implementation of warehouse management system CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Piper Sandler Conmed price target raised to $118 from $108 at Piper Sandler 10/26/22 Piper Sandler Conmed price target lowered to $108 from $118 at Piper Sandler 10/26/22 Piper Sandler Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem 10/14/22 Needham Conmed price target lowered to $90 from $123 at Needham CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Conmed sees FY23 adjusted EPS $3.20-$3.45, consensus $3.37 02/02/23 Conmed reports Q4 EPS 86c, consensus 90c 11/15/22 Conmed sees FY23 EPS $3.20-$3.50 , consensus $3.39 11/15/22 Conmed withdraws previously issued FY22 guidance CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Fly Intel: After-Hours Movers 10/26/22 Fly Intel: After-Hours Movers 03/08/23 Piper Sandler Hosted Company Meetings at AAOS 2023 Annual Meeting
Initiation	Privia Health initiated with a Buy at Goldman Sachs » 04:26 02/03/23 02/03 04:26 02/03/23 04:26 PRVA Privia Health $27.62 / +0.05 (+0.18%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events PRVA Privia Health $27.62 / +0.05 (+0.18%) 01/17/23 Privia Health announces launches of ACOs in Delaware and North Carolina 12/05/22 NeoGenomics names Jeffrey Sherman as new CFO 11/15/22 Privia Health announces Butler resigned from board of directors 10/03/22 Director of Privia Health sold 80,853 shares of company stock PRVA Privia Health $27.62 / +0.05 (+0.18%) 01/17/23 Piper Sandler Piper Sandler would be a buyer of Privia Health following CMS data 01/09/23 BTIG Privia Health price target lowered to $40 from $45 at BTIG 12/08/22 Stifel Privia Health initiated with a Buy at Stifel 12/08/22 UBS Privia Health initiated with a Buy at UBS PRVA Privia Health $27.62 / +0.05 (+0.18%) 11/10/22 Privia Health raises FY22 revenue view to $1.3B-$1.335B from $1.225B-$1.3B 11/10/22 Privia Health reports Q3 adjusted EPS 13c, consensus 0c 08/11/22 Privia Health sees 2022 revenue at high end of $1.225B-$1.3B 08/11/22 Privia Health reports Q2 adjusted EPS 13c vs. 9c last year. 17 Nov PRVA Privia Health $27.62 / +0.05 (+0.18%) 11/15/22 Fly Intel: After-Hours Movers 02/28/23 Privia Health - PRVA
Initiation	Agios Pharmaceuticals initiated with an Overweight at Piper Sandler » 04:25 02/03/23 02/03 04:25 02/03/23 04:25 AGIO Agios Pharmaceuticals $30.16 / +0.74 (+2.52%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AGIO Agios Pharmaceuticals $30.16 / +0.74 (+2.52%) 12/11/22 Agios Pharmaceuticals presents updated PYRUKYND long-term extension data 12/11/22 Agios Pharmaceuticals presents updated PYRUKYND data 12/06/22 Agios Pharmaceuticals appoints Tsveta Milanova as CCO 11/03/22 Agios Pharmaceuticals expects cash to fund operations through catalysts AGIO Agios Pharmaceuticals $30.16 / +0.74 (+2.52%) 11/17/22 Goldman Sachs Agios Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs 07/27/22 SVB Securities Agios Pharmaceuticals upgraded to Outperform from Market Perform at SVB Securities 02/25/22 RBC Capital Agios Pharmaceuticals price target raised to $67 from $61 at RBC Capital 02/24/22 H.C. Wainwright Agios Pharmaceuticals price target lowered to $96 from $98 at H.C. Wainwright AGIO Agios Pharmaceuticals $30.16 / +0.74 (+2.52%) 11/03/22 Agios Pharmaceuticals reports Q3 EPS ($1.49), consensus ($1.76) 08/04/22 Agios Pharmaceuticals reports Q2 EPS ($1.68), consensus ($1.75) AGIO Agios Pharmaceuticals $30.16 / +0.74 (+2.52%) 11/21/22 Biotech Alert: Searches spiking for these stocks today 02/23/23 Agios Pharmaceuticals - AGIO
General news	Market Update: » 03:05 02/03/23 02/03 03:05 02/03/23 03:05 $ECON Economic Data / + Market Update: Asian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals On The Fly $ECON Economic Data / + $ECON Economic Data / + 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says 01/22/23 Fed sets course for milder interest-rate rise next month, WSJ says 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says $ECON Economic Data / + 02/01/23 What You Missed On Wall Street On Wednesday 01/24/23 What You Missed On Wall Street On Tuesday 01/18/23 What You Missed On Wall Street On Wednesday 12/15/22 What You Missed On Wall Street On Thursday
General news	China economy bounces back thanks to services. » 02:25 02/03/23 02/03 02:25 02/03/23 02:25 $ECON Economic Data / + China economy bounces… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals On The Fly $ECON Economic Data / + $ECON Economic Data / + 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says 01/22/23 Fed sets course for milder interest-rate rise next month, WSJ says 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says $ECON Economic Data / + 02/01/23 What You Missed On Wall Street On Wednesday 01/24/23 What You Missed On Wall Street On Tuesday 01/18/23 What You Missed On Wall Street On Wednesday 12/15/22 What You Missed On Wall Street On Thursday
Conference/Events	Piper Sandler economist to hold an analyst/industry conference call » 22:33 02/02/23 02/02 22:33 02/02/23 22:33 Chief Economist Lazar and… Chief Economist Lazar and Head of Global Policy Perli discuss payrolls and their implications on an Analyst/Industry conference call to be held on February 3 at 8:45 am. Webcast Link
Conference/Events	Cowen medical devices analyst to hold analyst/industry conference call » 22:24 02/02/23 02/02 22:24 02/02/23 22:24 Medical Devices Analyst… Medical Devices Analyst Jennings, along with Dr. Shephal Doshi, Director of Cardiac Electrophysiology at Pacific Heart Institute, discuss the market dynamics of the U.S. Left Atrial Appendage Closure (LAAC) Duopoly on an Analyst/Industry conference call to be held on February 7 at 12:30 pm. Webcast Link
Syndicate	Avalo Therapeutics 3.77M share Spot Secondary priced at $3.98 » 21:56 02/02/23 02/02 21:56 02/02/23 21:56 AVTX Avalo Therapeutics $4.01 / +0.01 (+0.25%) SVB Securities and RBC… SVB Securities and RBC Capital are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate AVTX Avalo Therapeutics $4.01 / +0.01 (+0.25%) 01/17/23 Avalo Therapeutics completes target enrollment in Phase 2 PEAK trial 11/07/22 Avalo Therapeutics announces upcoming updates, milestones 11/07/22 Avalo sells economic rights to previously out-licensed assets for $5M 09/06/22 Avalo Therapeutics announces AVTX-008 has entered IND-enabling studies AVTX Avalo Therapeutics $4.01 / +0.01 (+0.25%) 11/09/22 Oppenheimer Avalo Therapeutics price target lowered to $10 from $17 at Oppenheimer 07/11/22 RBC Capital Avalo Therapeutics price target lowered to $21 from $24 at RBC Capital 03/03/22 Jefferies Avalo Therapeutics cut to Hold at Jefferies after pipeline reprioritization 03/03/22 Jefferies Avalo Therapeutics downgraded to Hold from Buy at Jefferies AVTX Avalo Therapeutics $4.01 / +0.01 (+0.25%) 11/07/22 Avalo Therapeutics reports Q3 EPS 34c vs ($2.08) last year 08/04/22 Avalo Therapeutics reports Q2 EPS ($1.38), consensus ($1.77) 03 Feb

Recommendations	Conmed price target raised to $118 from $108 at Piper Sandler » 21:55 02/02/23 02/02 21:55 02/02/23 21:55 CNMD Conmed $107.27 / +8.02 (+8.08%) Piper Sandler analyst… Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $118 from $108 and keeps an Overweight rating on the shares. The company unsurprisingly missed on Q4 earnings and revenue due to a previously disclosed Software Implementation issue, but this should be a transitory factor, the analyst tells investors in a research note. Conmed's key growth drivers - the Smoke business, In2Bones and Biorez - remain strong and should stay that way through 2023 and beyond, the firm adds. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Conmed: Results impacted by implementation of warehouse management system CNMD Conmed $107.27 / +8.02 (+8.08%) 10/26/22 Piper Sandler Conmed price target lowered to $108 from $118 at Piper Sandler 10/26/22 Piper Sandler Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem 10/14/22 Needham Conmed price target lowered to $90 from $123 at Needham 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Conmed sees FY23 adjusted EPS $3.20-$3.45, consensus $3.37 02/02/23 Conmed reports Q4 EPS 86c, consensus 90c 11/15/22 Conmed sees FY23 EPS $3.20-$3.50 , consensus $3.39 11/15/22 Conmed withdraws previously issued FY22 guidance CNMD Conmed $107.27 / +8.02 (+8.08%) 02/02/23 Fly Intel: After-Hours Movers 10/26/22 Fly Intel: After-Hours Movers 03/08/23 Piper Sandler Hosted Company Meetings at AAOS 2023 Annual Meeting 02/02/23 Conmed - CNMD
Syndicate	Roivant Sciences 26.67M share Secondary priced at $7.50 » 21:17 02/02/23 02/02 21:17 02/02/23 21:17 ROIV Roivant Sciences $7.58 / -0.99 (-11.55%) The deal size was… The deal size was increased to $200M from $150M and priced below last closing price of $7.59. Goldman Sachs, SVB Securities, Cowen and Cantor Fitzgerald are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ROIV Roivant Sciences $7.58 / -0.99 (-11.55%) 01/04/23 Roivant Sciences up 9% in pre-market at $7.78 after RVT-3101 phase 2b study data 01/04/23 Roivant Sciences announces 'positive' results from Phase 2b study of RVT-3101 12/01/22 Roivant Sciences, Pfizer form new Vant company focused on developing RVT-3101 11/10/22 Roivant's Affivant to present data on AFVT-2101 at SITC ROIV Roivant Sciences $7.58 / -0.99 (-11.55%) 01/05/23 Citi Roivant Sciences price target raised to $14 from $11 at Citi 01/04/23 Piper Sandler Prometheus, Roivant TL1A data look 'highly competitive,' says Piper 12/28/22 Cantor Fitzgerald Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks 12/27/22 Cantor Fitzgerald Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald ROIV Roivant Sciences $7.58 / -0.99 (-11.55%) 11/14/22 Roivant Sciences reports Q2 EPS (42c), consensus (41c) 08/15/22 Roivant Sciences reports Q1 EPS (48c) vs (13c) last year 03 Feb 08 Nov ROIV Roivant Sciences $7.58 / -0.99 (-11.55%) 02/01/23 Fly Intel: After-Hours Movers 11/14/22 Fly Intel: Pre-market Movers 10/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/19/22 Fly Intel: After-Hours Movers 03/17/23 2023 AAD Annual Meeting 02/13/23 Roivant Sciences - ROIV
Syndicate	Edible Garden 1.62M share Spot Secondary priced at $6.30 » 20:43 02/02/23 02/02 20:43 02/02/23 20:43 EDBL Edible Garden $8.35 / -2.8 (-25.11%) The deal priced below… The deal priced below last closing price of $8.35. Maxim and Joseph Gunnar are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings EDBL Edible Garden $8.35 / -2.8 (-25.11%) 01/31/23 Edible Garden AG Inc trading resumes 01/31/23 Edible Garden AG Inc trading halted, volatility trading pause 01/26/23 Edible Garden AG Inc trading resumes 01/26/23 Edible Garden AG Inc trading halted, volatility trading pause EDBL Edible Garden $8.35 / -2.8 (-25.11%) 09/13/22 Maxim Maxim starts Edible Garden at Buy on consistent produce growth and distribution 09/13/22 Maxim Edible Garden initiated with a Buy at Maxim EDBL Edible Garden $8.35 / -2.8 (-25.11%) 11/10/22 Edible Garden reports Q3 EPS (24c) vs (28c) last year 08/15/22 Edible Garden reports Q2 EPS (68c) vs (29c) last year
Hot Stocks	Dutch Bros CEO sells $6.0M in common stock » 20:39 02/02/23 02/02 20:39 02/02/23 20:39 BROS Dutch Bros $39.95 / +1.41 (+3.66%) In a regulatory filing,… In a regulatory filing, Dutch Bros disclosed that its CEO Jonathan Ricci sold 160K shares of common stock on February 1 in a total transaction size of $6.0M. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options BROS Dutch Bros $39.95 / +1.41 (+3.66%) 01/09/23 Dutch Bros rises 9.3% 11/09/22 Dutch Bros CEO: No good news on inflation 09/20/22 Dutch Bros appoints Victoria Tullett as chief legal officer 08/25/22 NIKE executive joins Dutch Bros board of directors BROS Dutch Bros $39.95 / +1.41 (+3.66%) 01/26/23 Barclays Dutch Bros price target raised to $31 from $29 at Barclays 01/24/23 Wedbush Dutch Bros initiated with a Neutral at Wedbush 01/05/23 Baird Baird remains very bullish on long-term fundamentals at Dutch Bros 01/05/23 Barclays Dutch Bros price target lowered to $29 from $30 at Barclays BROS Dutch Bros $39.95 / +1.41 (+3.66%) 11/09/22 Dutch Bros sees 2022 revenue at least $725M, consensus $724.5M 11/09/22 Dutch Bros reports Q3 EPS 9c, consensus 8c 08/10/22 Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M 08/10/22 Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c 16 Aug 11 Mar BROS Dutch Bros $39.95 / +1.41 (+3.66%) 10/06/22 Yum! Brands may look to buy another chain, Insider reports BROS Dutch Bros $39.95 / +1.41 (+3.66%) 08/10/22 Fly Intel: After-Hours Movers BROS Dutch Bros $39.95 / +1.41 (+3.66%) 01/12/23 Largest borrow rate increases among liquid names 01/06/23 Dutch Bros put volume heavy and directionally bearish 12/20/22 Largest borrow rate increases among liquid names 11/15/22 Largest borrow rate increases among liquid names
Earnings	Notable companies reporting before tomorrow's open » 20:25 02/02/23 02/02 20:25 02/02/23 20:25 CI Cigna $301.39 / -11.73 (-3.75%) , REGN Regeneron $751.22 / -5.9 (-0.78%) , ZBH Zimmer Biomet $127.40 / -0.3 (-0.23%) , CHD Church & Dwight $79.75 / -1.665 (-2.05%) , SAIA Saia $287.01 / -8.69 (-2.94%) Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Cigna (CI), consensus $4.86... Regneron (REGN), consensus $10.03... Zimmer Biomet (ZBH), consensus $1.83... Church & Dwight (CHD), consensus 60c... Saia (SAIA), consensus $2.83. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ZBH SAIA REGN CI CHD ZBH Zimmer Biomet $127.40 / -0.3 (-0.23%) 01/05/23 Zimmer Biomet to acquire Embody for $155M at closing 11/30/22 NeuroOne Medical ships initial Zimmer Biomet order for Evo sEEG system 11/21/22 Zimmer Biomet announces FDA 510(k) clearance of Persona OsseoTi Keel Tibia 11/05/22 Zimmer Biomet announces one-year data from mymobility clinical study SAIA Saia $287.01 / -8.69 (-2.94%) 12/04/22 Fly Intel: Top five weekend stock stories 12/01/22 Saia reports October LTL shipments down 4.4%, November-to-date down 8.6% 10/31/22 Saia sees 2022 net capital expenditures $500M 09/07/22 Saia reports August LTL shipments per workday declined 1.9% REGN Regeneron $751.22 / -5.9 (-0.78%) 01/30/23 Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization 01/27/23 Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent 01/06/23 2seventy Bio announces amendment to collaboration with Regeneron 01/05/23 CytomX Therapeutics updates business, announces 2023 relationship with Moderna CI Cigna $301.39 / -11.73 (-3.75%) 02/02/23 Managed care stocks pressured after CMS' preliminary Medicare Advantage rates 01/12/23 California AG files suit against drugmakers, PBMs over insulin prices 12/06/22 Walmart to pay $500,000 over workers' compensation prescription procedures 11/07/22 WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD CHD Church & Dwight $79.75 / -1.665 (-2.05%) 09/06/22 Church & Dwight to acquire Hero Mighty Patch for $630M CI REGN ZBH CHD SAIA CI Cigna $301.39 / -11.73 (-3.75%) 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/03/23 Wells Fargo Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355 01/03/23 Wells Fargo Cigna downgraded to Equal Weight from Overweight at Wells Fargo 11/23/22 Morgan Stanley Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley REGN Regeneron $751.22 / -5.9 (-0.78%) 01/30/23 Cowen Regeneron upgraded at Cowen with Eylea 'secure' and pipeline 'delivering' 01/30/23 Cowen Regeneron upgraded to Outperform from Market Perform at Cowen 01/20/23 JPMorgan Regeneron upgraded to Overweight from Neutral at JPMorgan 01/09/23 Piper Sandler Piper 'at a loss' to explain Regeneron Q4 miss for Eylea ZBH Zimmer Biomet $127.40 / -0.3 (-0.23%) 01/09/23 RBC Capital Zimmer Biomet upgraded to Outperform from Sector Perform at RBC Capital 01/05/23 Piper Sandler Zimmer Biomet price target raised to $130 from $120 at Piper Sandler 01/05/23 Raymond James Zimmer Biomet upgraded to Outperform from Market Perform at Raymond James 01/03/23 Evercore ISI Zimmer Biomet downgraded to In Line at Evercore ISI with FY23 outlook priced in CHD Church & Dwight $79.75 / -1.665 (-2.05%) 01/17/23 Credit Suisse Church & Dwight upgraded to Outperform from Neutral at Credit Suisse 01/16/23 Morgan Stanley Church & Dwight upgraded to Overweight from Equal Weight at Morgan Stanley 01/13/23 JPMorgan Church & Dwight price target raised to $81 from $75 at JPMorgan 12/06/22 Deutsche Bank Church & Dwight price target raised to $90 from $85 at Deutsche Bank SAIA Saia $287.01 / -8.69 (-2.94%) 01/30/23 Credit Suisse Saia downgraded to Neutral from Outperform at Credit Suisse 01/09/23 Susquehanna Saia downgraded to Neutral from Positive at Susquehanna 01/09/23 Morgan Stanley Saia upgraded to Equal Weight from Underweight at Morgan Stanley 12/01/22 BofA Saia cut to Underperform at BofA after Q4 shipment update ZBH SAIA REGN CI CHD ZBH Zimmer Biomet $127.40 / -0.3 (-0.23%) 11/02/22 Zimmer Biomet narrows FY22 adjusted EPS view to $6.90-$6.90 from $6.70-$6.90 11/02/22 Zimmer Biomet reports Q3 adjusted EPS $1.58, consensus $1.55 SAIA Saia $287.01 / -8.69 (-2.94%) 10/31/22 Saia reports Q3 EPS $3.67, consensus $3.70 REGN Regeneron $751.22 / -5.9 (-0.78%) 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 11/03/22 Regeneron reports Q3 EPS $11.14, consensus $9.48 CI Cigna $301.39 / -11.73 (-3.75%) 02/02/23 Notable companies reporting before tomorrow's open 11/03/22 Cigna raises FY22 adjusted EPS view to at least $23.10 from at least $22.90 11/03/22 Cigna reports Q3 adjusted EPS $6.04, consensus $5.71 11/02/22 Notable companies reporting before tomorrow's open CHD Church & Dwight $79.75 / -1.665 (-2.05%) 10/28/22 Church & Dwight sees Q4 adjusted EPS 58c-62c, consensus 72c 10/28/22 Church & Dwight sees 2022 adjusted EPS $2.93-$2.97, consensus $2.97 10/28/22 Church & Dwight reports Q3 EPS 76c, consensus 65c SAIA REGN CI SAIA Saia $287.01 / -8.69 (-2.94%) 12/03/22 Tapestry, Saia among small-cap stocks set for big gains, Barron's says REGN Regeneron $751.22 / -5.9 (-0.78%) 11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says 09/16/22 WHO panel recommends against GSK, Regeneron COVID drugs, Bloomberg reports CI Cigna $301.39 / -11.73 (-3.75%) 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 11/07/22 Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports ZBH SAIA REGN CI CHD ZBH Zimmer Biomet $127.40 / -0.3 (-0.23%) 01/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SAIA Saia $287.01 / -8.69 (-2.94%) 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/03/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations REGN Regeneron $751.22 / -5.9 (-0.78%) 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/30/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/20/23 What You Missed On Wall Street On Friday CI Cigna $301.39 / -11.73 (-3.75%) 01/27/23 What You Missed On Wall Street This Morning 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 Fly Intel: Pre-market Movers CHD Church & Dwight $79.75 / -1.665 (-2.05%) 11/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/17/22 What You Missed On Wall Street On Monday 10/17/22 What You Missed On Wall Street This Morning 03/09/23 Biopharma/Biotech 02/24/23 Annual Meeting of AAAAI 2023 08:30 Today Cigna - CI 08:30 Today Regeneron - REGN 08:30 Today Zimmer Biomet - ZBH 11:00 Today Saia - SAIA 13:00 Today Church & Dwight - CHD 02/11/23 PDUFA Date for EYLEA (Aflibercept) Injection 02/28/23 PDUFA 03/30/23 PDUFA Date for Evkeeza (evinacumab) 00:00 Today Church & Dwight REGN CI CHD REGN Regeneron $751.22 / -5.9 (-0.78%) 09/16/22 Early notable gainers among liquid option names on September 16th 09/09/22 Early notable gainers among liquid option names on September 9th 09/08/22 Early notable gainers among liquid option names on September 8th 08/03/22 Early notable gainers among liquid option names on August 3rd CI Cigna $301.39 / -11.73 (-3.75%) 01/13/23 Early notable gainers among liquid option names on January 13th CHD Church & Dwight $79.75 / -1.665 (-2.05%) 01/17/23 Early notable gainers among liquid option names on January 17th

Events

Earnings calls, analyst events, roadshows and more

AVTR
Today at 08:00

Avantor - AVTR Conference Calls
TWST
Today at 08:00

Twist Bioscience - TWST Conference Calls
SNY
Today at 08:00

Sanofi - SNY Conference Calls
Today at 08:30

Employment Situation: Average Hourly Earnings M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Average Hourly Earnings Y/Y: January 2023 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: January 2023 Government Event
Today at 08:30

Employment Situation: Average Workweek: January 2023 Government Event
Today at 08:30

Employment Situation: Private Payrolls M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Manufacturing Payrolls M/M: January 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	VERA X VERA Vera Therapeutics Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LIFC Priced at: $7.00 14.286M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ALGM X ALGM Allegro MicroSystems Block Trade Managers: Credit Suisse Priced at: $38.00 4.98M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPCR X GPCR Structure Therapeutics IPO Managers: Jefferies, SVB Securities, Guggenheim & BMO Capital Priced at: $15.00 10.74M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ROIV X ROIV Roivant Sciences Secondary Managers: Goldman Sachs, SVB Securities, Cowen & Cantor Fitzgerald Priced at: $7.50 26.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVTX X AVTX Avalo Therapeutics Spot Secondary Managers: SVB Securities & RBC Capital Priced at: $3.98 3.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDBL X EDBL Edible Garden Spot Secondary Managers: Maxim & Joseph Gunnar Priced at: $6.30 1.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	WULF X WULF TeraWulf Spot Secondary Managers: JonesResearch $1.03
Thurs	ASST X ASST Asset Entities IPO Managers: Boustead $5.00 1.5M Shares SODR X SODR Sondors IPO Managers: DA Davidson & Lake Street $8.00 - 10.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDXH X MDXH MDxHealth Secondary Managers: Cowen & William Blair, BTIG, KBCS $6.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CLLS X CLLS Cellectis Spot Secondary Managers: Jefferies & Barclays $3.26 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TWO X TWO Two Harbors Spot Secondary Managers: Goldman Sachs, JPMorgan & Citi, JMP Securities $17.80-18.00 10M Shares
Fri	No deals

View All Syndicate Announcements »

JPMorgan upgrades AssetMark Financial on medium term position

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access